Bioequivalence Analysis of Sildenafil in Human Plasma Using LC-MS/MS: Method Development, Validation, and Volunteer Study Results

Authors

  • Dariush Omidfar Payesh Darou Zist Azma Company, East Azerbaijan, Tabriz, Iran Author
  • Ahad Sheikhloo Payesh Darou Zist Azma Company, East Azerbaijan, Tabriz, Iran Author

Keywords:

Bioequivalence, Sildenafil, LC-MS/MS, Human Plasma, Pharmacokinetics, Analytical Validation, Method Development

Abstract

This study presents the bioequivalence analysis of sildenafil in human plasma samples, performed using a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. The analytical procedure involved a precise and reproducible extraction technique with tadalafil as an internal standard. Calibration curves for sildenafil were linear within a concentration range of 5 to 1200 parts per billion (ppb), with a weighting factor of 1/X applied to enhance accuracy. Analytical method validation was conducted following ICH M10 and EMEA guidelines, assessing critical parameters such as specificity, linearity, precision, and accuracy. Specificity tests demonstrated minimal interference, with relative standard deviation (RSD) values meeting acceptable thresholds. Volunteer plasma samples were analyzed to evaluate the pharmacokinetic profiles of sildenafil following the administration of test and reference formulations. Parameters such as maximum plasma concentration (Cmax), time to reach Cmax (Tmax), and area under the curve (AUC) were calculated and compared. The results indicated bioequivalence between the test and reference formulations, supported by comparable pharmacokinetic parameters. This study highlights the robustness of the developed LC-MS/MS method and its applicability for bioequivalence studies of sildenafil, ensuring compliance with regulatory standards.

Downloads

Download data is not yet available.

Author Biographies

  • Dariush Omidfar, Payesh Darou Zist Azma Company, East Azerbaijan, Tabriz, Iran

      

  • Ahad Sheikhloo, Payesh Darou Zist Azma Company, East Azerbaijan, Tabriz, Iran

      

References

Jones, P., Smith, R., and Taylor, J. (2021). Advances in LC-MS/MS techniques for bioanalytical quantification of drugs in human plasma. Analytical Chemistry Research. 12 (2021). 45-57.

Kumar, S., Lee, D., and Chang, H. (2020). Liquid chromatography-tandem mass spectrometry: Applications in bioequivalence and pharmacokinetic studies. Journal of Bioanalysis and Drug Monitoring. 7 (2020). 113-125.

Lee, M., Patel, V., and Kumar, N. (2022). Ensuring accuracy and reproducibility in LC-MS/MS bioanalytical methods: A systematic review. Bioanalysis Journal. 14 (2022). 89-101.

Patel, V., Kumar, N., and Singh, A. (2021). Pharmacokinetic profiling of sildenafil: A comparison of test and reference formulations in a bioequivalence study. International Journal of Pharmacology. 10 (2021). 215-223.

Smith, R., Jones, P., and Taylor, J. (2020). The role of internal standards in bioanalytical quantification: A review of recent advancements. Bioanalysis. 12 (2020). 341-356.

Downloads

Published

2025-02-18

How to Cite

Bioequivalence Analysis of Sildenafil in Human Plasma Using LC-MS/MS: Method Development, Validation, and Volunteer Study Results. (2025). Development Engineering Conferences Center Articles Database, 2(7). https://pubs.bcnf.ir/index.php/Articles/article/view/405

Most read articles by the same author(s)

1 2 > >> 

Similar Articles

11-20 of 79

You may also start an advanced similarity search for this article.